Clin2
NCT07429253Possibly a fitRecruiting

Secretome vs. PRP for male and female hair loss

Androgenetic Alopecia

Treatments studied

Part of Skin clinical trials.

This trial compares two treatments—secretome and platelet-rich plasma (PRP)—to see which helps grow thicker, denser hair in people with genetic hair loss (androgenetic alopecia). It's for adults aged 25 to 59 who have stopped taking certain hair loss medications for at least a month.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
40 people
Ages
25 years to 59 years
Study type
Interventional

Who can take part

  • You are 25 to 59 years old.
  • You have male or female pattern hair loss (diagnosed by a doctor).
  • You have not used minoxidil or anti-androgen medications for at least 1 month.
  • You are not pregnant or breastfeeding (if female).
  • You have no active scalp infections, dermatitis, or known allergies to the treatments.
  • You can understand Indonesian and agree to be in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06558565Not yet recruiting
Fat stem cells vs. PRP for male hair loss

This study compares two treatments for male pattern hair loss: a special injection made from your own fat cells (called stromal vascular fraction) versus a platelet-rich plasma (PRP) injection. Both are designed to help regrow hair.

Cairo
NCT07739147Not yet recruiting· Early Phase 1
PRP vs Light-Enhanced PRP for Pattern Hair Loss

This study compares two types of platelet-rich plasma (PRP) injections — one is standard PRP, the other is PRP that is 'light-enhanced' with special light exposure — to see which works better for treating hair loss due to male or female pattern baldness. If you're struggling with thinning hair, this trial may help you find a more effective non-surgical option.

NCT07618195Recruiting· Phase 1/Phase 2
Testing EPI-001 for male and female pattern hair loss

This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.

Seoul, Seoul
NCT07112586Not yet recruiting· Phase 1/Phase 2
Exosome injections for male pattern baldness

This trial tests whether injections of exosomes (tiny particles from cells) can help regrow hair in men with mild to moderate male pattern baldness. It may offer a new treatment option without surgery.

Cairo, Abbasia
NCT06826001Not yet recruiting· Phase 2
Procedural treatments for male pattern baldness

This study compares different office-based procedures to treat male pattern hair loss. It may help men who want to try non-surgical options to slow or reverse hair thinning.

Rahim Yar Khan, Punjab Province
NCT07758400Not yet recruiting
Microneedling for male pattern baldness

This study tests whether microneedling, a procedure that uses tiny needles to stimulate the scalp, can help treat male pattern baldness. It may help regrow hair in men with moderate to advanced hair loss.

Beijing, Beijing Municipality

Hear when a new Androgenetic Alopecia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.